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In human tissues phytanic acid is &-oxidized to pristanic acid in peroxisomes. Studies of the intraorganellar site of a-oxidation of [l-‘4C]phytanic 
acid to pristanic acid in peroxisomes isolated from human liver demonstrate that phytanoyl-CoA ligase is present in the peroxisomal membrane 
and that the enzyme system for cc-oxidation of phytanic acid to pristanic acid is in the peroxisomal matrix. In contrast to the /I-oxidation system 
for fatty acids, the substrate for a-oxidation is free phytanic acid. The studies described in this manuscript report a novel fatty acid oxidation system 
where the substrate for the enzyme system is free fatty acid; however, phytanoyl-CoA ligase regulates the a-oxidation of phytanic acid at the 
organellar (peroxisomal) level. 
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1. INTRODUCTION 
The daily human diet is estimated to contain 50-100 
mg of phytanic acid (3,7,11,15-tetramethylhexade- 
canoic acid), a highly branched fatty acid [l] and exces- 
sive amounts of phytanic acid accumulate in a number 
of neurological diseases [2]. The fact that only trace 
amounts of phytanic acid are present in normal tissues 
in spite of large consumption (X&100 mg/day) suggests 
that there must be an efficient catabolic pathway which 
disposes of the ingested phytanic acid. Due to the pres- 
ence of a methyl group at the /?-carbon of phytanic acid 
it first undergoes a-oxidation to pristanic acid followed 
by further degradation by B-oxidation [ 11. Recent stud- 
ies with purified subcellular organelles uggest hat per- 
oxisomes are the major site of a-oxidation of phytanic 
acid to pristanic acid in human tissues [3,4]. The specific 
activity for a-oxidation of phytanic acid in isolated per- 
oxisomes from human cultured skin fibroblasts was 29- 
and 124-fold higher than in mitochondria and micro- 
somes [3,4]. The excessive accumulation of phytanic 
acid, as the result of a defect in a-oxidation of phytanic 
acid, in patients with diseases with a defect in the bio- 
genesis of peroxisomes (e.g. Zellweger Syndrome) also 
suggests that peroxisomes may be the site for a-oxida- 
tion of phytanic acid [1,2,5]. The deficient a-oxidation 
of phytanic acid only in peroxisomes from peroxisomal 
disorders, classical Refsum Disease [6] and Rhizomelic 
Chondrodysplasia Punctata [4], as compared to the nor- 
mal activities in mitochondria and microsomes from 
patients with Refsum Disease, Zellweger Syndrome and 
Rhizomelic Chondrodysplasia Punctata support the 
conclusion that in humans the peroxisome is the pri- 
mary site of a-oxidation of phytanic acid to pristanic 
acid. 
The activation of phytanic acid to phytanoyl-CoA is 
prerequisite for its a-oxidation [3,4,6,7]. Therefore, a- 
oxidation of phytanic acid to pristanic acid constitutes 
four steps: activation of phytanic acid to phytanoyl- 
CoA, a-hydroxylation of phytanic acid to a-hy- 
droxyphytanic acid, formation of 2-oxophytanic acid, 
and finally decarboxylation to pristanic acid and CO, 
[ l&9]. As peroxisomes are the major site of a-oxidation 
of phytanic acid in human tissues, we examined the 
intraperoxisomal distribution of enzyme activities for 
activation (phytanoyl-CoA ligase) and a-oxidation of 
phytanic acid. These studies demonstrate that phy- 
tanoyl-CoA ligase is localized in the peroxisomal mem- 
brane and that the enzyme system for a-oxidation of 
phytanic acid is present in the matrix of peroxisomes. 
The activation of phytanic acid to phytanoyl-CoA was 
required for its a-oxidation only in intact peroxisomes 
but not in isolated matrix or permealized peroxisomes. 
This suggests that phytanic acid is the true substrate. 
The activation of phytanic acid to phytanoyl-CoA may 
be required for the transport of phytanic acid through 
the peroxisomal membrane for its a-oxidation in the 
matrix. 
*Corresponding author. Fax: (1) (803) 792 2033. 
2. MATERIALS AND METHODS 
Nycodenz was obtained from Accurate Chemical and Scientific 
Corp., Westbury, NY, ATP and CoASH were purchased from P-L 
Biochemicals, Milwaukee, WI; Desulfo-CoA , naproxen and digitonin 
were purchased from Sigma Chemical Co., St.Louis, MO; Triton 
X-100 was purchased from Bio-Rad Laboratories, Melville, NY; 
[I-Qphytanic acid (55mCi/mmol) was purchased from Amersham 
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Intemational, Arlington Heights, IL.; and [l-‘4qph~anoyl COA was 
synthesized as described [IO]. 
Peroxisomes from human liver were isolated according to the proce- 
dures described previously [ 11,121. The fractions containing the cata- 
lase peak were pooled and dialyzed against he homogenization buffer 
[3,4,12] for 2 h to lower the concentration of nycodenz. Peroxisomal 
integrity was measured by the latency of catalase activity, a matrix 
enzyme. Total catalase activity was measured by diluting peroxisomes 
1:l with 2% of Triton X-100. The free catalase activity was measured 
by suspending peroxisomes in homogenization buffer in the absence 
of Triton X-100. The percent otal catalase activity minus percent free 
catalase is an index of peroxisomal integrity. To separate the mem- 
brane and matrix of peroxisomes, peroxisomes were incubated with 
digitonin (0.2 ms/ml) for 1 h at 4°C and then centrifuged at 50,000 rpm 
for 1 h in a Beckman 70 Ti rotor. Separation of membrane (residue) 
and matrix (soluble) was confirmed by measuring catatase activity. 
Catalase activity was present only in the matrix, and not in the mem- 
branes. 
The oxidation of phytanic acid to pristanic acid was measured as 
14C0, released from [l-‘4C]phytanic acid according to the method 
described previously [3,4&j. Briefly, the reaction volume of 0.25 ml 
contained 12 PM [l-‘4C]phyt~c acid, 30 mM KCl, 5 mM MgCl,, 50 
FM CoASH, 10 mM ATP, 0.25 mM NADPH, 0.17 mM FAD, and 
20 mM MOPS-HCI, pH 7.8 in 0.25 M sucrose. The reaction was 
started by the addition of 20-50 pg of protein and stopped with 50 ,uI 
of 5 N H,SO, after 2 h. “‘CO, was collected in KOH-wetted cotton by 
shaking over night and then radioactivity was measured. 
Phytanoyl CoA ligase activity was measured as mentioned earlier 
[13]. Briefly, tire reaction mixture of 0.5 ml contained 12 PM 
~l-‘4C]phytanic acid, 50 mM KCl, 5 mM MgCl,, 50 I.IM CoASH, 
f 0 mM ATP, and 30 mM MOPS-HCI buffer, pH 7.8. 
The transport of phytanoyl-CoA into peroxisomes was studied as 
described previously [12]. Briefly, the peroxisomes were incubated 
with [l-‘4C]phytanoyl- CoA under isotonic conditions for 10 min, they 
were then separated from the incubation medium by centrifuging 
through an organic layer of brominat~ hydrocarbons into an aque- 
ous layer at the bottom of the tube containing 0.396 M sucrose, 1 mM 
EDTA in 3 mM imidazole buffer, pH 7.4, as cushion. The radioactiv- 
ity in the bottom layer (cushion) containing the sedimented per- 
oxisomes was measured as an index of phytanoyl- CoA transported 
mto peroxisomes. The radioactivity that migrated through organic 
layer with the disrupted peroxisomes was used as the blank [12]. 
Protein con~ntrations were measured by the method of Bradford 1141. 
3. RESULTS AND DISCUSSION 
Recently we have demonstrated that in human tissues 
phytanic acid is a-oxidized to pristanic acid in per- 
oxisomes [3,4,6]. The activation of phytanic acid to phy- 
tanoyl-CoA by phytanoyl-CoA ligase is an initial and 
obligatory step in its cc-oxidation in peroxisomes [3,4,7]. 
The phytanoyl-CoA ligase present in peroxisomes is a 
different enzyme than the other known acyl-CoA ligases 
such as palmitoyl-CoA ligase and lignoceroyl-CoA li- 
gase /73. The intraperoxisom~ identification of the en- 
zyme system for a-oxidation of phytanic acid is neces- 
sary for understanding the nature of the associated en- 
zyme system and the molecular mechanism of the inher- 
ited defects in the degradation of phytanic acid in 
Refsum Disease, Rhizomelic chon~~ysplasia punc- 
tata and other peroxisomal diseases. 
Peroxisomes are made up of a granular matrix sur- 
rounded by a single limiting membrane. The matrix 
proteins are released as soluble proteins as soon as the 
Table I 
Activation and oxidation of phytanic acid by intact peroxisomes and 
membrane and matrix of peroxisomes isolated from human liver 
Sets Naproxen Activation Oxidation (pmol/h/mp/ 




Peroxisomes - 13.34 f 1.77 35.53 + 4.08 36.23 4: 3.94 
+ 3.08 f 0.21 9.31 + 2.16 33.35 Z!I 2.50 
Membrane - 19.86 ? 2.55 1.36 ? 0.61 0.97 Z!Z 0.26 
+ 4.46 f 0.75 1.07 + 0.35 0.66 t 0.15 
Matrix 0 17.48 + 2.25 16.85 t 2.60 
+ 0 16.20 + 1.92 15.72 I!Z 2.15 
The enzyme activities were measured as described in the text. The 
results are expressed as mean + SD. of duplicate values from at least 
three different preparations. 
peroxisomal limiting membrane is disrupted 1151. To 
understand the intraperoxisomal organization of the en- 
zyme system for a-oxidation of phytanic acid, the en- 
zyme activities for the activation of phytanic acid by 
phytanoyl-CoA ligase and a-oxidation of phytanic acid 
was studied in highly purified intact peroxisomes (over 
95% purity) [I 1,121 and in the matrix and membranes 
isolated following digitonin treatment of the purified 
peroxisomes and digitonin permealized peroxisomes as 
described in Section 2. The enzyme activity for the acti- 
vation of phytanic acid by phytanoyl-CoA ligase was 
observed in the ~roxisomal membrane, but not the 
matrix proteins, whereas the enzyme activity for a-oxi- 
dation of phytanic acid or phytanoyl-CoA to pristanic 
acid was found in the peroxisomal matrix proteins 
(Table I). The rate of a-oxidation of phytanic acid was 
13-times higher in the matrix (17.48 + 2.25 pmol/h/mg 
protein) than that in the peroxisomal membranes (1.36 
pmoyhlmg protein) (Table I). These results suggest hat 
similar to the fatty acid /?-oxidation system, phytanic 
acid is activated in peroxisomal membranes and then 
oxidized to pristanic acid in the matrix of peroxisomes. 
Consistent with previous observations, Naproxen, an 
inhibitor of acyl-CoA ligases [16], inhibited the a-oxida- 
tion of phytanic acid and not of phytanoyl-CoA in in- 
tact peroxisomes, again suggesting that biosynthesis of 
phytanoyl-CoA is a necessary and intermediatory step 
in the a-oxidation of phytanic acid in intact per- 
oxisomes. However, surprisingly, we observed that free 
phytanic acid can be oxidized in the matrix 
(17.48 _+ 2.25 pmol/h/mg protein) as efficiently as phy- 
tanoyl-CoA (16.85 + 2.60 pmol/h/mg protein) suggest- 
ing that phytanic acid may be the substrate for ol-oxi- 
dase in the matrix (Table I). The inability of Naproxen 
to inhibit a-oxidation of free phytanic acid in the iso- 
lated matrix proteins also supports the conclusion that 
free phytanic acid may be the substrate for a-oxidation 
enzyme system. We observed that 90% of the phy- 
tanoyl-CoA was hydrolyzed to free phytanic acid, in 
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Fig. 1. (A) Effect of cofactors and metal ions on the rate of phytanic 
acid a-oxidation in peroxisomes (A, complete medium containing 
ATP, CoASH and MgCI,; B, minus CoASH; C, minus MgCl,; D, 
minus ATP; E, minus CoASH, MgClz and ATP; F, Complete medium 
plus digitonin; G, minus CoASH, MgCl, and ATP but plus digitonin). 
Peroxisomes were incubated with digitonin (0.1 mg/ml) for 1 h at 4°C. 
100% activity for phytanic acid oxidation was 35.53 f 4.08 pmol/h/mg 
protein. (B) Effect of naproxen and desulfo CoA on phytanic acid 
a-oxidation by peroxisomes. Phytanic acid oxidation in peroxisomes 
isolated from human liver was measured (A, control peroxisomes; B, 
with naproxen; C, with desulfo CoA; D, with digitonin; E, with di- 
gitonin and naproxen; F, with digitonin and desulfo CoA) as described 
previously [5,6,9]. Peroxisomes uspended in homogenization buffer 
were preincubated with either 50,uM naproxen or 50,~M desulfo CoA 
and where indicated along with Digitonin (0.1 mg/ml) for 1 h at 4” C. 
100% activity for phytanic acid oxidation was 35.53 + 4.08 pmol/h/mg 
protein. 
assay conditions when phytanoyl-CoA was incubated 
with matrix protein, by acyl-CoA hydrolase present in 
peroxisomes [ 121 suggesting that free phytanic acid may 
be the true substrate for oxidation of phytanic acid in 
the matrix of peroxisomes. We also examined the a- 
oxidation of phytanic acid in conditions in which the 
cofactors and metal ions required for the activation of 
fatty acids were deleted or substituted by a nonfunc- 
tional cofactor (e.g. desulfo-CoA) in intact peroxisomes 
and peroxisomes permealized with digitonin (Fig. 1). 
The a-oxidation of phytanic acid was inhibited by dele- 
tion of individual or all cofactors required for the acti- 
vation of phytanic acid to phytanoyl-CoA only in intact 
peroxisomes but not in the digitonin permealized per- 
oxisomes (Fig. 1A). Similarly, the substitution of 
CoASH by desulfo-CoA, an analog of CoASH which 
does not support activation of fatty acids, inhibits a- 
oxidation of phytanic acid only in intact peroxisomes 
but not in permealized peroxisomes (Fig. 1B). The ob- 
served activity (20-25%) of phytanic acid a-oxidation in 
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intact peroxisomal preparation in the absence of fatty 
acid activating cofactors or in the presence of desulfo- 
CoA was proportional to the percent of broken per- 
oxisomes in these conditions. These studies also support 
the conclusion that phytanic acid, and not phytanoyl- 
CoA, is the true substrate for the phytanic acid a-oxida- 
tion system. The permealization of peroxisomes with 
digitonin treatment of peroxisomes inhibited the a-oxi- 
dation of phytanic acid by approximately 15% (Fig. 1). 
The loss of activity in isolated matrix (17.48 + 2.25 
pmol/h/mg protein) as compared to intact peroxisomes 
(35.53 + 4.08 pmoYh/mg protein) and permealized per- 
oxisomes (29.36 f 3.87 pmol/h/mg protein) may be due 
to the inactivation of the enzyme during the isolation of 
membrane and matrix as the addition of membranes to 
the matrix fraction did not result in an increase in activ- 
ity (data not shown here). 
To further establish that free phytanic acid is a true 
substrate for a-oxidation, we examined the status of 
phytanoyl-CoA transported into intact peroxisomes 
and its rate of a-oxidation (Fig. 2). The transport of 
phytanoyl-CoA into intact peroxisomes was studied as 
described in Section 2, and the status of phytanoyl-CoA 
in peroxisomes was studied by Dole partition [ 171 of the 
radioactive fatty acid after transport assay into aqueous 
phase (phytanoyl-CoA) and organic phase (free 
phytanic acid). As shown in Fig. 2, at zero time 97% of 
the fatty acid transported into peroxisomes was phy- 
tanoyl-CoA. However, phytanoyl-CoA was quickly hy- 
drolyzed to free phytanic acid in intact peroxisomes 
(Fig. 2). Thirty minutes following its transport into per- 
oxisomes 68% of the phytanoyl-CoA was hydrolyzed to 
free phytanic acid, and 99% of phytanoyl-CoA was hy- 
drolyzed at 60 min. These results suggest that per- 
oxisomes have a very active phytanoyl-CoA hydrolase 
which quickly degrades phytanoyl-CoA to phytanic 
acid. In a parallel experiment, the rate of a-oxidation 
of phytanic acid, transported into peroxisomes, was de- 
termined at different time intervals after the transport 
assay. The rate of a-oxidation of phytanic acid into 
peroxisomes was linear up to 3 h, very much later than 
the time when phytanoyl-CoA is hydrolyzed to free 
phytanic acid (Fig. 2). The fact that phytanoyl-CoA is 
quickly hydrolyzed to free phytanic acid in intact per- 
oxisomes and production of 14C02 continues even at 
times when 99% of the transported phytanoyl-CoA was 
hydrolyzed to free phytanic acid supports the conclu- 
sion that free phytanic acid is the true substrate for its 
a-oxidation in peroxisomes. 
Phytanoyl-CoA ligase is an enzyme distinct from the 
other known acyl-CoA ligases such as palmitoyl-CoA 
ligase and lignoceroyl-CoA ligase which are present in 
the peroxisomal membrane [7,18]. The higher specific 
activities of phytanoyl-CoA ligase and phytanic acid 
a-oxidation in peroxisomes from human tissues and in 
mitochondria from rat tissues suggests that subcellular 
distribution of phytanoyl-CoA ligase controls the site of 
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Fig. 2. The status of phytanoyl-CoA following transport into peroxisomes and its o-oxidation. Peroxisomes were incubated with [I-?Z]phytanoyl- 
CoA for 10 min and transport of phytanoyl-CoA into peroxisomes was measured by separating the peroxisomes from the incubating medium by 
centrifuging through the organic layer into an aqueous cushion at the bottom of the tube [12]. The radioactivity in the bottom aqueous layer 
containing peroxisomes was measured as the phytanoyl-CoA transported into pcroxisomes. The status of phytanoyl-CoA, transported into 
peroxisomes, was measured by Dole partition [17] of radioactivity (fatty acid) in peroxisomes into aqueous (phytanoyl-CoA, O-O) and organic (free 
phytanic acid, o-o) phases after different time intervals following the transport assay. The 100% activity of phytanoyl-CoA into peroxisomes, at 
0 time in the bottom acqueous phase, was 8490 dpm. In a parallel experiment the rate of formation of WO, (O-O) was measured as an index of 
z-oxidation of phytanic acid in peroxisomes from the bottom aqueous layer at different time periods following the separation of peroxisomes from 
the medium by centrifuging through the organic layer in the transport assay [12]. 
phytanic acid oxidation by providing the phytanoyl- 
CoA for oxidation. The strict requirement for activa- 
tion of phytanic acid to phytanoyl-CoA for a-oxidation 
in intact peroxisomes, but not in permealized per- 
oxisomes or isolated matrix, clearly demonstrates that 
the function of phytanoyl-CoA ligase in peroxisomal 
membrane may be to synthesize phytanoyl-CoA for its 
transport into peroxisomes. This implies that the active 
site of phytanoyl-CoA ligase is on the cytoplasmic sur- 
face of the peroxisomal membrane and that the phy- 
tanoyl-CoA synthesized on the cytoplasmic surface en- 
ters the peroxisomal matrix where it is hydrolyzed to 
free phytanic acid and then a-oxidized to pristanic acid. 
The active site of palmitoyl-CoA ligase is on the cyto- 
plasmic surface of the peroxisomal membrane and that 
of lignoceroyl-CoA ligase on the luminal surface [ 181. 
Consistent with the topology of the active site of palmi- 
toyl-CoA and lignoceroyl-CoA ligases in the per- 
oxisomal membrane, palmitoyl-CoA is synthesized on 
the cytoplasmic surface and transported as palmitoyl- 
CoA, whereas lignoceric acid is transported into per- 
oxisomes as such and then activated to lignoceroyl-CoA 
on the luminal surface of the membrane prior to its 
B-oxidation in the matrix [12]. Although the subcellular 
site for j%oxidation of pristanic acid has not been clearly 
established, the excessive accumulation and defective 
oxidation of pristanic acid in diseases which lack per- 
oxisomes [191 suggests that the degradation of pristanic 
acid by B-oxidation in human tissues also takes place in 
peroxisomes. Except for acyl-CoA ligases, the other en- 
zymes for p-oxidation of fatty acids are present in the 
peroxisomal matrix [17,21]. The actual substrates for 
fatty acid /?-oxidation are the acyl-CoA derivatives. The 
finding that phytanic acid is a-oxidized to pristanic acid 
in the matrix of peroxisomes uggests that for /I-oxida- 
tion of pristanic acid, a product of phytanic acid a- 
oxidation, needs to be activated to pristanoyl-CoA 
prior to /?-oxidation. However, at present it is not 
known whether pristanic acid is activated to pristanoyl- 
CoA by a putative pristanoyl-CoA ligase, with the ac- 
tive site being on the luminal surface, or by lignoceroyl- 
CoA ligase, the active site of which lies on the luminal 
surface of peroxisomes [18]; or that whether it first 
leaves the peroxisomes for its activation on the cyto- 
plasmic surface and then re-enters the peroxisomes for 
its B-oxidation. 
In summary: in peroxisomes the phytanoyl-CoA li- 
gase is present in the peroxisomal membrane and en- 
zyme system for a-oxidation of phytanic acid to pris- 
tanic acid is in the matrix of peroxisomes. The efficient 
oxidation of free phytanic acid in permealized per- 
oxisomes or isolated peroxisomal matrix as compared 
to the absolute requirement for activation of phytanic 
acid to phytanoyl-CoA in intact peroxisomes uggests 
that phytanoyl-CoA ligase in the peroxisomal mem- 
brane regulates the a-oxidation of phytanic acid by pro- 
viding phytanoyl-CoA for its entry into peroxisomes. 
The conclusion that the free phytanic acid is the true 
substrate for the enzyme system for a-oxidation of 
phytanic acid in the matrix of peroxisomes is supported 
by the following observations. (i) The a-oxidation of 
phytanic acid in isolated matrix or permealized per- 
oxisomes with digitonin did not require fatty acid acti- 
vating cofactors (e.g. ATP, CoASH). (ii) The a-oxida- 
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tion of phytanic acid in isolated matrix or perrnealized 
peroxisomes was not inhibited by naproxen, an inhibi- 
tor of acyl-CoA ligases. (iii) Phytanoyl-CoA is quickly 
hydrolyzed to free phytanic acid following its transloca- 
tion into intact peroxisomes. (iv) The a-oxidation of 
phytanic acid continued at a linear rate for 2 h past the 
time when all of the phytanoyl-CoA was hydrolyzed to 
free phytanic acid. 
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